for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

SeaSpine Holdings Corp

SPNE.OQ

Latest Trade

12.21USD

Change

0.11(+0.91%)

Volume

41,581

Today's Range

12.03

 - 

12.24

52 Week Range

10.45

 - 

20.72

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
12.10
Open
12.08
Volume
41,581
3M AVG Volume
0.86
Today's High
12.24
Today's Low
12.03
52 Week High
20.72
52 Week Low
10.45
Shares Out (MIL)
19.06
Market Cap (MIL)
233.04
Forward P/E
-6.13
Dividend (Yield %)
--

Next Event

SeaSpine Holdings Corp Analyst & Investor Meeting

Latest Developments

More

SeaSpine Posts Q2 Loss Per Share Of $0.64

SeaSpine Sees FY 2019 Revenue Up About 7.5 To 9 Percent

Seaspine Holdings Corp Files For Mixed Shelf Of Up To $150 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About SeaSpine Holdings Corp

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures.

Industry

Medical Equipment & Supplies

Contact Info

5770 Armada Dr

+1.760.7278399

http://www.seaspine.com

Executive Leadership

Keith C. Valentine

President, Chief Executive Officer

John J. Bostjancic

Chief Financial Officer, Treasurer, Secretary

Paul Benny

Vice President, Controller, Assistant Treasurer, Assistant Secretary

Troy Woolley

Vice President - Marketing, Spine Hardware

Brian D. Baker

Vice President, Global Operations

Key Stats

1.40 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.1K

2017

0.1K

2018

0.1K

2019(E)

0.2K
EPS (USD)

2016

-3.850

2017

-2.580

2018

-2.180

2019(E)

-1.975
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.56
Price To Book (MRQ)
1.88
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-33.93
Return on Equity (TTM)
-27.51

Latest News

BRIEF-SeaSpine Qtrly Loss Per Share $0.56

* SEASPINE ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 RESULTS AND ISSUES 2018 FINANCIAL GUIDANCE

BRIEF-Seaspine Sees FY 2017 Revenue $132 Million To $132.2 Million

* SEASPINE ANNOUNCES PRELIMINARY RESULTS FOR FOURTH QUARTER AND FULL-YEAR 2017

BRIEF-SeaSpine Posts FDA 510(K) Clearance Of Osteoballast Demineralized Bone Matrix In Resorbable Mesh

* SEASPINE ANNOUNCES FDA 510(K) CLEARANCE OF OSTEOBALLAST™ DEMINERALIZED BONE MATRIX IN RESORBABLE MESH

BRIEF-Seaspine Holdings reports qtrly diluted earnings per share loss $0.58

* Seaspine Holdings Corp - qtrly diluted earnings per share loss $0.58

BRIEF-SeaSpine announces launch of Shoreline Anterior Cervical Standalone system​

* SeaSpine Holdings Corp - announced full commercial launch of Shoreline Anterior Cervical Standalone system Source text for Eikon: Further company coverage:

BRIEF-Seaspine Q2 revenue $34.2 mln vs I/B/E/S view $33.4 mln

* Seaspine Holdings Corp - qtrly net loss per share, basic and diluted $0.68 Source text for Eikon: Further company coverage:

BRIEF-Seaspine Holdings says limited commercial launch of, completion of initial cases for skipjack expandable interbody system

* Seaspine Holdings Corp - limited commercial launch of and completion of initial cases for its skipjack expandable interbody system Source text for Eikon: Further company coverage:

BRIEF-Seaspine sees Q2 revenue $34 mln to $34.2 mln

* SeaSpine announces preliminary results for second quarter 2017

BRIEF-SeaSpine Holdings reports Q1 net loss per share $0.79

* Sees FY 2017 revenue $129 million to $133 million Source text for Eikon: Further company coverage:

BRIEF-Seaspine reports qtrly loss per share $0.87

* Seaspine announces fourth quarter and full year 2016 results and issues 2017 financial guidance

BRIEF-SEASPINE ANNOUNCES FULL COMMERCIAL LAUNCH OF VU APOD PRIME NANOMETALENE SYSTEM

* FULL COMMERCIAL LAUNCH OF ITS VU APOD PRIME NANOMETALENE SYSTEM Source text for Eikon: Further company coverage:

BRIEF-SeaSpine announces preliminary results for Q4 and FY 2016

* SeaSpine Holdings Corp - Preliminary and unaudited revenue for Q4 2016 is expected to be in range of $32.5 to $32.7 million

BRIEF-Seaspine to cut jobs

* Company initiated reduction-in-force that will contribute to an overall reduction in its current employee base of approximately 8%

BRIEF-SeaSpine says received clearance from FDA of mariner posterior fixation system

* Company expects a full commercial launch of mariner system in first half of 2017

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up